Scarica l'app Stockscreener
10.99
3.88%
0.41
Dopo l'orario di chiusura:
10.99
Precedente Chiudi:
$10.58
Aprire:
$10.46
Volume 24 ore:
123.33K
Relative Volume:
0.49
Capitalizzazione di mercato:
$237.66M
Reddito:
-
Utile/perdita netta:
$-35.46M
Rapporto P/E:
-26.06
EPS:
-0.4218
Flusso di cassa netto:
$-34.00M
1 W Prestazione:
+9.35%
1M Prestazione:
+89.48%
6M Prestazione:
+75.84%
1 anno Prestazione:
-37.80%
Intervallo 1D:
$10.30
$11.16
Intervallo di 1 settimana:
$9.85
$11.63
Portata 52W:
$3.35
$20.30
Contineum Therapeutics Inc Stock (CTNM) Company Profile
Nome
Contineum Therapeutics Inc
Settore
Industria
Telefono
(858) 333-5280
Indirizzo
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
Confronta CTNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
10.99 | 313.23M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-20 | Iniziato | William Blair | Outperform |
| 2024-10-22 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-30 | Iniziato | Morgan Stanley | Overweight |
| 2024-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-30 | Iniziato | Stifel | Buy |
Contineum Therapeutics Inc Borsa (CTNM) Ultime notizie
Why is Contineum Therapeutics Inc. stock going down2025 Momentum Check & Fast Gaining Stock Reports - khodrobank.com
Key metrics from Contineum Therapeutics Inc.’s quarterly data2025 Performance Recap & Real-Time Buy Signal Alerts - Newser
Is Contineum Therapeutics Inc. trending in predictive chart modelsTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
Price momentum metrics for Contineum Therapeutics Inc. explainedEntry Point & Free Technical Confirmation Trade Alerts - Newser
Can volume confirm reversal in Contineum Therapeutics Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Is Contineum Therapeutics Inc. meeting your algorithmic filter criteria2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Chart based analysis of Contineum Therapeutics Inc. trendsWeekly Market Summary & Long-Term Growth Stock Strategies - Newser
Using data tools to time your Contineum Therapeutics Inc. exit2025 Support & Resistance & Long-Term Safe Return Strategies - Newser
Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of “Buy” from Analysts - Defense World
Is Contineum Therapeutics Inc. stock ready for a breakoutJuly 2025 Big Picture & Weekly Top Gainers Alerts - Newser
Can machine learning forecast Contineum Therapeutics Inc. recoveryJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
Is Contineum Therapeutics Inc. gaining market shareEntry Point & Intraday High Probability Alerts - khodrobank.com
Real time breakdown of Contineum Therapeutics Inc. stock performanceWeekly Risk Summary & Proven Capital Preservation Tips - Newser
Contineum Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - sisaissue.com
Does Contineum Therapeutics Inc. have pricing powerJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - khodrobank.com
News impact scoring models applied to Contineum Therapeutics Inc.Trade Volume Summary & Daily Chart Pattern Signals - Newser
How to build a dashboard for Contineum Therapeutics Inc. stock2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Analyzing Contineum Therapeutics Inc. with multi timeframe chartsAnalyst Downgrade & Weekly Watchlist for Hot Stocks - Newser
Will Contineum Therapeutics Inc. benefit from green energy policies2025 Earnings Impact & Low Drawdown Investment Ideas - خودرو بانک
Published on: 2025-09-01 14:59:33 - Newser
Will Contineum Therapeutics Inc. benefit from seasonalityJuly 2025 Setups & Growth Oriented Trading Recommendations - khodrobank.com
How liquid is Contineum Therapeutics Inc. stockJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - khodrobank.com
Tick level data insight on Contineum Therapeutics Inc. volatility2025 Stock Rankings & Daily Market Momentum Tracking - Newser
How institutional ownership impacts Contineum Therapeutics Inc. stockTrade Ideas & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-31 15:27:26 - Newser
Chart based exit strategy for Contineum Therapeutics Inc.Weekly Loss Report & Low Drawdown Investment Ideas - Newser
What data driven models say about Contineum Therapeutics Inc.’s future2025 Price Targets & Low Risk Growth Stock Ideas - Newser
Long term hold vs stop loss in Contineum Therapeutics Inc.2025 Year in Review & Free Community Consensus Stock Picks - Newser
What machine learning models say about Contineum Therapeutics Inc.July 2025 Summary & Reliable Volume Spike Alerts - Newser
What the charts say about Contineum Therapeutics Inc. today2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Will Contineum Therapeutics Inc. outperform small cap indexes getLinesFromResByArray error: size == 0 - sisain.net
Using flow based indicators on Contineum Therapeutics Inc.Earnings Recap Report & Fast Moving Stock Watchlists - Newser
Does Contineum Therapeutics Inc. qualify in momentum factor screeningWeekly Trade Summary & Community Consensus Trade Signals - Newser
Will earnings trigger a reversal in Contineum Therapeutics Inc.Market Risk Summary & Community Consensus Picks - Newser
Can swing trading help recover from Contineum Therapeutics Inc. losses2025 Retail Activity & Safe Entry Point Alerts - Newser
How to use a screener to detect Contineum Therapeutics Inc. breakouts2025 Growth vs Value & Fast Exit and Entry Strategy Plans - Newser
Contineum Therapeutics Inc Azioni (CTNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Contineum Therapeutics Inc Azioni (CTNM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lorrain Daniel S. | Chief Scientific Officer |
Nov 18 '24 |
Sale |
16.38 |
6,190 |
101,421 |
169,572 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):